Skip to main content
×
×
Home

Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL)

  • Kathryn A. Ellis (a1) (a2) (a3), Cassandra Szoeke (a3) (a4), Ashley I. Bush (a2), David Darby (a2), Petra L. Graham (a5), Nicola T. Lautenschlager (a1) (a6), S. Lance Macaulay (a4), Ralph N. Martins (a7), Paul Maruff (a8), Colin L. Masters (a2), Simon J. McBride (a4), Kerryn E. Pike (a9), Stephanie R. Rainey-Smith (a7), Alan Rembach (a2), Joanne Robertson (a2), Christopher C. Rowe (a10) (a11), Greg Savage (a5), Victor L. Villemagne (a2) (a10), Michael Woodward (a12), William Wilson (a4), Ping Zhang (a4), David Ames (a1) (a3) and the AIBL Research Group...
Abstract
Background:

The Australian Imaging, Biomarkers and Lifestyle (AIBL) Flagship Study of Ageing is a prospective study of 1,112 individuals (211 with Alzheimer's disease (AD), 133 with mild cognitive impairment (MCI), and 768 healthy controls (HCs)). Here we report diagnostic and cognitive findings at the first (18-month) follow-up of the cohort. The first aim was to compute rates of transition from HC to MCI, and MCI to AD. The second aim was to characterize the cognitive profiles of individuals who transitioned to a more severe disease stage compared with those who did not.

Methods:

Eighteen months after baseline, participants underwent comprehensive cognitive testing and diagnostic review, provided an 80 ml blood sample, and completed health and lifestyle questionnaires. A subgroup also underwent amyloid PET and MRI neuroimaging.

Results:

The diagnostic status of 89.9% of the cohorts was determined (972 were reassessed, 28 had died, and 112 did not return for reassessment). The 18-month cohort comprised 692 HCs, 82 MCI cases, 197 AD patients, and one Parkinson's disease dementia case. The transition rate from HC to MCI was 2.5%, and cognitive decline in HCs who transitioned to MCI was greatest in memory and naming domains compared to HCs who remained stable. The transition rate from MCI to AD was 30.5%.

Conclusion:

There was a high retention rate after 18 months. Rates of transition from healthy aging to MCI, and MCI to AD, were consistent with established estimates. Follow-up of this cohort over longer periods will elucidate robust predictors of future cognitive decline.

Copyright
Corresponding author
Correspondence should be addressed to: Kathryn A. Ellis, Academic Unit for Psychiatry of Old Age, Department of Psychiatry, University of Melbourne, 155 Oak Street Parkville, VIC 3052, Australia. Phone: +61-39389-2919; Fax: +61-39387-5061. Email: kellis@unimelb.edu.au.
References
Hide All
American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Health Disorders, 4th edn. Washington, DC: American Psychiatric Association.
Buckley, R. et al. (2013). Cognitive and affective predictors of subjective memory complaints in the Australian Imaging Biomarkers and Lifestyle (AIBL) study of aging: a cross-sectional analysis. International Psychogeriatrics, 7, S239.
Craig, C. L. et al. (2003). International physical activity questionnaire: 12-country reliability and validity. Medicine and Science in Sports and Exercise, 35, 13811395.
Delis, D., Kramer, J., Kaplan, E. and Ober, B. (2000). California Verbal Learning Test-Second Edition. San Antonio, TX: The Psychological Corporation.
Delis, D. C., Kaplan, E. and Kramer, J. H. (2001). The Delis-Kaplan Executive Function System (D-KEFS). San Antonio, TX: The Psychological Corporation.
Ellis, K. A. et al. (2009). The Australian Imaging Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease. International Psychogeriatrics, 21, 672687.
Folstein, M. F., Folstein, S. E. and McHugh, P. R. (1975). “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189198.
Jorm, A. F. and Jacomb, P. A. (1989). The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychological Medicine, 19, 10151022.
Kurz, A. and Lautenschlager, N. L. (2010). Established treatements for Alzheimer's disease: cholinesterase inhibitors and memantine. In Ames, D., Burns, A. and O'Brien, J. (eds.), Dementia, 4th edn. (pp. 471483). London: Hodder.
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology, 34, 939944.
Mewton, L., Sachdev, P., Anderson, T., Sunderland, M. and Andrews, G. (2013). Demographic, clinical, and lifestyle correlates of subjective memory complaints in the Australian population. American Journal of Geriatric Psychiatry, doi: 10.1016/j.jagp.2013.04.004.
Meyers, J. E. and Meyers, K. R. (1995). Rey Complex Figure Test and Recognition Trial: Professional Manual. Lutz, FL: Psychological Assessment Resource, Inc.
Morris, J. C. (1993). The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology, 43, 24122414.
Morris, J. C. et al. (2012). Developing an international network for Alzheimer research: the Dominantly Inherited Alzheimer Network. Clinical Investigation (London), 2, 975984.
Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G. and Kokmen, E. (1999). Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology, 56, 303308.
Reiman, E. M. et al. (2011). Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments. Journal of Alzheimer's Disease, 26, 321329.
Rowe, C. C. et al. (2010). Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Imaging beta-amyloid burden in aging and dementia. Neurobiology of Aging, 31, 12751283.
Savage, G. (2010). Neuropsychological assessment of dementia. In Ames, D., Burns, A. and O'Brien, J. (eds.), Dementia, 4th edn. (pp. 6167). London: Hodder.
Saxton, J. et al. (2000). Normative data on the Boston Naming Test and two equivalent 30-item short forms. Clinical Neuropsychology, 14, 526534.
Schneider, L. S., Insel, P. S., Weiner, M. W. and the Alzheimer's Disease Neuroimaging Initiative (2011). Treatment with cholinesterase inhibitors and memantine in patients in the Alzheimer's Disease Neuroimaging Initiative. Archives of Neurology, 68, 5866.
Sheikh, J. I. and Yesavage, J. A. (1986). Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. In Clinical Gerontology: Guide to Assessment and Intervention (pp. 165173). New York: The Haworth Press.
Slavin, M. J. et al. (2010). Prevalence and predictors of “subjective cognitive complaints” in the Sydney Memory and Ageing Study. American Journal of Geriatric Psychiatry, 18, 701710.
Snaith, R. P. and Zigmond, A. S. (1986). The hospital anxiety and depression scale. British Medical Journal (Clinical Research Ed.), 292, 344.
Sona, A. et al. (2012). Predictors of rapid decline in Alzheimer's disease: results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of ageing. International Psychogeriatrics, 24, 197204.
Sperling, R. A. et al. (2011). Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers & Dementia, 7, 280292.
Strauss, E., Sherman, E. M. S. and Spreen, O. (2006). A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary, 3rd edn. New York: Oxford University Press.
Wechsler, D. (1945). A standardised memory scale for clinical use. Journal of Psychology, 19, 8795.
Wechsler, D. (1997). Wechsler Adult Intelligence Scale–Third Edition (WAIS-III). San Antonio, TX: The Psychological Corporation.
Wechsler, D. (2001). Wechsler Test of Adult Reading: Examiner's Manual. San Antonio, Texas: The Psychological Corporation.
Winblad, B. et al. (2004). Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. Journal of Internal Medicine, 256, 240246.
World Health Organization (1992). ICD-10 Classifications of Mental and Behavioural Disorder: Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organization.
Zigmond, A. S. and Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67, 361370.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

International Psychogeriatrics
  • ISSN: 1041-6102
  • EISSN: 1741-203X
  • URL: /core/journals/international-psychogeriatrics
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed